DR.REDDY'S LABORATORIES

L85195TG1984PLC004507 · ISIN INE089A01031 · 3 filings, FY 2022-23 to FY 2024-25 · consolidated basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

CategoryFY 2022-23FY 2023-24FY 2024-25
Plastics including packaging not filednot filed0
E-waste not filednot filed0
Hazardous waste not filednot filed813
Other waste 16,80031,37610,105
Total reclaimed 16,80031,37610,918

Recycled or reused input material

Share of total material by value, per material line as the company named it. Each line carries its own denominator, so they are never summed or averaged.

Input material, as filedFY 2022-23FY 2023-24FY 2024-25
Not applicable 0.0%0.0%0.0%

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
21009 Development, manufacturing & sale of generic formulations including biosimilars and consumer healthcare 89.00%
21009 Development, manufacturing & sale of active pharmaceutical ingredients & custom pharmaceutical services 11.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Consolidated 2023-06-30 1,69,625
FY 2023-24 Consolidated basis 2024-04-30 1,94,838
FY 2024-25 Consolidated 2024-04-30 2,31,15,40,00,000

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error